Rohto Pharmaceutical Co.,Ltd.
RPHCF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $3 | $682 | $5 | $706 |
| - Cash | $1 | $77 | $0 | $65 |
| + Debt | $0 | $50 | $0 | $45 |
| Enterprise Value | $3 | $655 | $4 | $686 |
| Revenue | $1 | $1 | $1 | – |
| % Growth | 3.1% | -0.1% | – | – |
| Gross Profit | $0 | $0 | $0 | – |
| % Margin | 55.3% | 54.7% | 57.4% | – |
| EBITDA | $0 | $0 | $0 | – |
| % Margin | 23.8% | 15.2% | 23.9% | – |
| Net Income | $0 | $0 | $0 | – |
| % Margin | 14.4% | 7.5% | 13.7% | – |
| EPS Diluted | 0.36 | 0.18 | 0.33 | – |
| % Growth | 100% | -45.5% | – | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |